Literature DB >> 25952062

Nonopioid medications for pain.

David Tauben1.   

Abstract

Evidence of nonopioid analgesic effectiveness exceeds that for long-term opioids in chronic noncancer pain (CNCP), most with lower risk. Non-drug therapies such as cognitive behavioral therapy and physical activation are safer and also effective. Nonsteroidal antiinflammatory drugs are useful for inflammatory and nociceptive pain, share renal and variable gastrointestinal, bleeding and cardiovascular side effects. Antidepressants with noradrenergic activity (such as tricyclics and seroton-norepinephrine reuptake inhibitors) and neuromodulating anticonvulsant drugs (gabapentinoids and sodium-channel blockers) are proven to be effective for neuropathic and centralized pain. Ketamine and cannabinoids are other studied analgesics but have a less well-proven role in CNCP.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetaminophen; Anticonvulsant; Antidepressant; Benzodiazepine; Central sensitization; NSAID; Neuropathic pain; Opioid

Mesh:

Substances:

Year:  2015        PMID: 25952062     DOI: 10.1016/j.pmr.2015.01.005

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  8 in total

1.  Neuroanatomical characterization of imidazoline I2 receptor agonist-induced antinociception.

Authors:  Justin N Siemian; Shushan Jia; Jian-Feng Liu; Yanan Zhang; Jun-Xu Li
Journal:  Eur J Neurosci       Date:  2018-03-23       Impact factor: 3.386

Review 2.  Novel Therapies for Centralized Pain: a Brief Review.

Authors:  Jade I Basem; Paul Ryan Haffey
Journal:  Curr Pain Headache Rep       Date:  2022-09-28

3.  Interactions between imidazoline I2 receptor ligands and acetaminophen in adult male rats: antinociception and schedule-controlled responding.

Authors:  Justin N Siemian; Jiuzhou Li; Yanan Zhang; Jun-Xu Li
Journal:  Psychopharmacology (Berl)       Date:  2015-11-28       Impact factor: 4.530

4.  Cody.

Authors:  Stephen M Milner; James A Fauerbach; Anne Hahn; Leigh Ann Price; Linda Ware; Kelly Krout; Elizabeth Panter; Nicole Kiehle Pharm; James Pfeiffer; Hien Nguyen; Geeta Sood; Kamal Dhanjani; Genevieve McKeon; Kevin Gerold
Journal:  Eplasty       Date:  2015-08-06

5.  Difficulties with assessment and management of an infant's distress in the postoperative period: Optimising opportunities for interdisciplinary information-sharing.

Authors:  Carlye Weiner; Sueann Penrose; Elizabeth Manias; Noel Cranswick; Ellie Rosenfeld; Fiona Newall; Allison Williams; Narelle Borrott; Sharon Kinney
Journal:  SAGE Open Med Case Rep       Date:  2016-12-14

Review 6.  A systematic review of the effectiveness of policies restricting access to pregabalin.

Authors:  Brett R Stacey; Jonathan Liss; Regina Behar; Alesia Sadosky; Bruce Parsons; Elizabeth T Masters; Patrick Hlavacek
Journal:  BMC Health Serv Res       Date:  2017-08-25       Impact factor: 2.655

7.  A MAPP Network Case-control Study of Urological Chronic Pelvic Pain Compared With Nonurological Pain Conditions.

Authors:  Niloofar Afari; Dedra Buchwald; Daniel Clauw; Barry Hong; Xiaoling Hou; John N Krieger; Chris Mullins; Alisa J Stephens-Shields; Marianna Gasperi; David A Williams
Journal:  Clin J Pain       Date:  2019-09-26       Impact factor: 3.423

Review 8.  Managing Neuropathic Pain in Dogs.

Authors:  Sarah A Moore
Journal:  Front Vet Sci       Date:  2016-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.